328 results
-
Review of the Marketing in Australia of Infant Formulas: Manufacturers and Importers Agreement (MAIF Agreement)
We are seeking feedback to inform the Review of the Marketing in Australia of Infant Formulas: Manufacturers and Importers Agreement (MAIF Agreement). The MAIF Agreement is a voluntary, self-regulatory code of conduct between manufacturers and importers of infant formula products in Australia. The key objectives of the MAIF Agreement are to: ensure safe and adequate nutrition for babies encourage breastfeeding as the first option for babies ... MoreClosed 12 May 2023 -
Volunteers in aged care survey
Do you volunteer or work with volunteers in the aged care sector? Take part in our volunteering survey. Volunteers are an important part of the aged care system freely giving their time, companionship, care, and support. As part of the Australian Government’s response to the Royal Commission into Aged Care Quality and Safety, the Department is currently seeking the views of: all people who volunteer in the aged care sector, and all those who work with volunteers... MoreClosed 26 May 2023 -
A New Model for Regulating Aged Care - Details of the proposed new model - Workshop Registration
Registration for June 2023 workshops has now closed. If you have any questions or queries please contact agedcareregmodel@health.gov.au MoreClosed 6 June 2023 -
Development of the Fourth National Hepatitis B Strategy 2023-2030 and Sixth National Hepatitis C Strategy 2023-2030 - Public Consultation Online Survey
Ensuring Australians can live free from the impact of hepatitis B and hepatitis C is a priority of the Australian Government. We are seeking your feedback on the draft Fourth National Hepatitis B Strategy 2023-2030 and the draft Sixth National Hepatitis C Strategy 2023-2030 (the Strategies). These Strategies are part of the new draft national Blood Borne Viruses (BBV) and Sexually Transmissible Infections (STI) strategies that will build on the... MoreClosed 28 June 2023 -
National Diabetes Services Scheme (NDSS) Products
The National Diabetes Services Scheme (NDSS) provides subsidised access to a range of products for the self-management of diabetes. To ensure the products supplied under the NDSS continue to meet the needs of people registered with the scheme – and represent value-for-money for the Australian Government – the Department of Health and Aged Care is planning a tender process to refresh the NDSS Product Schedule. The tender would allow new and existing product suppliers to... MoreClosed 2 July 2023 -
Improving alignment and coordination between the Medical Research Future Fund and Medical Research Endowment Account
This consultation closed on 14 July 2023. The Australian Government is committed to ensuring health and medical research investment delivers the greatest benefit to the community while driving long-term economic sustainability. To optimise the government’s investment in health and medical research, the Department of Health and Aged Care and National Health and Medical Research Council (NHMRC) are undertaking national consultation to improve alignment and coordination... MoreClosed 14 July 2023 -
Public Health (Tobacco and Other Products) Legislation 2023
We are analysing your feedback Visit this page again soon for the outcomes to this public consultation. Public Consultation on the Exposure Draft On 30 November 2022 the Hon. Mark Butler MP Minister for Health and Aged Care announced tobacco reforms. These reforms bring together current legislation and introduce new measures to reduce tobacco prevalence. The Australian Government is now consulting on the exposure draft legislation for these reforms. The... MoreClosed 14 July 2023 -
Proposed Changes to the HPV Vaccine Recommendation
The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to the human papillomavirus (HPV) vaccination recommendations in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical Research Council (NHMRC) for its approval under section 14A of the National Health and Medical Research Council Act 1992. The draft recommendations and the rationale for the... MoreClosed 20 July 2023 -
National Health and Climate Strategy - Consultation
The Australian Government is developing a National Health and Climate Strategy. The strategy aims to protect the health and wellbeing of Australians from the effects of climate change. To do this, it is important for the Australian Government to: reduce greenhouse gas emissions from the health system make the health system more resilient to the impacts of climate change support communities to take action against the health effects of... MoreClosed 24 July 2023 -
Consultation on [the] Guide to prepare an application to the Prescribed List of Benefits for Medical Devices and Human Tissue Products
The purpose of this consultation is to seek feedback from stakeholders on the draft Guide to prepare an application to the Prescribed List of Benefits for Medical Devices and Human Tissue Products (the Guide). The Guide will assist applicants to prepare an application to list a product on the Prescribed List of Benefits for Medical Devices and Human Tissue Products (the PL), or to amend an existing billing code. The draft Guide refers to links and other... MoreClosed 28 July 2023 -
Prostheses List Reforms Consultation Paper 7 - Proposed measures for compliance, assurance and information sharing
The purpose of this paper is to provide stakeholders information about: proposed compliance and assurance measures; and proposed measures to promote information sharing among government agencies about medical devices and human tissue products included in the Prescribed List . As part of this consultation, we invited stakeholders to attend an information webinar on Tuesday 1 August 2023, where we discussed the proposed measures, answered... MoreClosed 10 August 2023 -
Consultation on the Private Health Insurance (PHI) Incentives and Hospital Default Benefits Studies
Independent studies were announced in the 2020-21 and 2021-22 Budgets and covered the following: The effectiveness of the regulatory settings for the Medicare Levy Surcharge (MLS), Rebate, and Lifetime Health Cover (LHC) (collectively referred to as the PHI Incentives); and Hospital Default Benefits. The aim of these studies is to identify opportunities to improve the affordability and quality of PHI cover for consumers to access private... MoreClosed 15 August 2023 -
Draft National Consumer Engagement Strategy for Health and Wellbeing
A NATIONAL CONSUMER ENGAGEMENT STRATEGY FOR HEALTH AND WELLBEING: This Strategy is designed to strengthen partnerships between health policy makers and the community, as set out in one of the immediate priorities for action under the National Preventive Health Strategy 2021-2030. The purpose of this Strategy is to mobilise a person-centred prevention system by involving communities and consumers in preventive health policy design and implementation in order to enable and support a more... MoreClosed 4 September 2023 -
Final Report for CHSP Ad Hoc Proposals funding (From Funding Payment to 30 June 2023)
Overview of Reporting on CHSP Ad Hoc Funding The CHSP Ad Hoc Proposals grant was published under Grant Opportunity GO5672 (for financial year 2022-2023) as an extension of the Grant Opportunity GO4265 (for financial years 2020-2021 and 2021-2022). Funding provided through the CHSP Ad Hoc Proposals grant enabled organisations to respond to unforeseen and exceptional circumstances, address gaps in service delivery and trial and implement new and innovative service... MoreClosed 8 September 2023 -
Shigella SoNG Working Group Survey - Case definitions
Background information from the Shigella SoNG Working Group is required to progress document development that is consistent with the needs of as many jurisdictions as possible. MoreClosed 11 September 2023 -
SSD Performance Report: 1 January - 30 June 2023
Under the Commonwealth Home Support Programme (CHSP) grant agreement, Sector Support and Development (SSD) providers are required to submit a Performance Report to the Department of Health and Aged Care (Department) bi-annually. This performance report will be used to gather information that may inform future policy and analyse demand for services as aged care reforms are implemented. It is no t intended to communicate changes to SSD policy. ... MoreClosed 14 September 2023 -
Preparing for, and responding to, future pandemics and other international health emergencies
Australia is participating in two important processes to strengthen the international community’s capacity to prevent, prepare for, and respond to, pandemics and other international health emergencies: the negotiation of a new international legal instrument on pandemic prevention, preparedness and response, and targeted changes to the International Health Regulations (2005) (IHR) through the World Health Organization (WHO). To date, Member States... MoreClosed 24 September 2023 -
Medicare Benefits Schedule (MBS) Review Advisory Committee: Post implementation review of changes to colonoscopy MBS items
The Medicare Benefits Schedule (MBS) is a list of health professional services (items) that the Australian Government subsidises. MBS items provide patient benefits for a wide range of health services including consultations, diagnostic tests, therapy, and operations. When changes are made to MBS items, a review is undertaken approximately 24 months after to analyse and examine the performance of the changes. This is called a post implementation review. Post implementation... MoreClosed 29 September 2023 -
Public Consultation: Industrially-produced trans fats in processed foods - EXTENDED
Consultation period extended until 29 September 2023. In August 2019 the Australia and New Zealand Ministerial Forum on Food Regulation (now the Food Ministers’ Meeting) asked the Food Regulation Standing Committee to consider options to improve the composition of the food supply in relation to trans fats. This consultation has been prepared by the Food Regulation Standing Committee (FRSC) to support consideration of regulatory and non-regulatory options for... MoreClosed 29 September 2023 -
Stocktake on Residential Aged Care Accommodation Design
The Department of Health and Aged Care is seeking information from aged care providers on the design of residential aged care accommodation. The Stocktake on the Design of Residential Aged Care Accommodation (‘stocktake’) will help the department to understand what residential aged care accommodation looks like from a design perspective. This information will be used to develop a picture of aged care homes, including where services are provided flexibly, in terms... MoreClosed 3 October 2023 -
Access to scientific journal articles
One of the top 3 regulatory science priorities identified at our office planning day was to “retain and resource access to the full range of scientific literature”. With this priority in mind, the following short survey is designed to gain a better understanding of how the office accesses, uses and stores scientific journal articles, with the aim of improving the way this is currently done. MoreClosed 6 October 2023 -
Prostheses List Reforms – PwC Report on Reforms to the Prostheses List Part B – May 2023
We are seeking feedback from stakeholders on the PricewaterhouseCoopers' (PwC) report and recommendations on the proposed reforms to Part B of the Prescribed List of Benefits for Medical Devices and Human Tissue Products* (the PL), and the proposed restructure of Part B. The report outlines a way forward agreed between the department and key stakeholders in terms of the new structure of Part B, and the listing process to be used for new products, and also includes amendments to... MoreClosed 6 October 2023 -
Feedback on the draft National Microbial Genomics Framework 2024-2025
Microbial genomics is the application of genome sequencing technologies to characterise and analyse pathogens for the purposes of informing clinical and public health investigation and response to communicable disease outbreaks. The implementation of this technology is rapidly transforming the Australian pathology sector and its accelerated implementation to support the COVID-19 response, provides a unique opportunity to leverage its value in understanding and controlling other... MoreClosed 10 October 2023 -
Unleashing the potential of our workforce - Scope of Practice Review
In February 2023, the Strengthening Medicare Taskforce Report outlined priority recommendations to improve primary care. One of these was that the Australian Government work together with states and territories to explore the barriers and incentives for all health practitioners to work to their full scope of practice. In April 2023, National Cabinet supported this recommendation. As part of the 2023-24 Budget, the Government provided funding for a review of the scope of... MoreClosed 16 October 2023 -
Public Consultation: Intellectual Disability Health Capability Framework
Health professionals need the right knowledge, skills and attitudes to care for people with intellectual disability. The Department of Health and Aged Care (the Department) is leading the Intellectual Disability Health Curriculum Development Project, a priority action under the National Roadmap for Improving the Health of People with Intellectual Disability , to support universities and accreditation authorities to improve pre-registration education for health professionals to better... MoreClosed 27 October 2023 -
Modernising My Health Record – Sharing pathology and diagnostic imaging reports by default and removing consumer access delays
In February 2023 the Minister for Health and Aged Care released the Strengthening Medicare Taskforce Report . The report recommended that the government: Modernise My Health Record to significantly increase health information available to consumers and their health care professionals, including by requiring sharing by default for private and public practitioners and services, and make it easier for people and their health care teams to use at the point of care. ... MoreClosed 31 October 2023 -
Co-design of the new national mental health lived experience family/carer/kin peak body
The Australian Government values the contributions of people with lived and/or living experiences of mental ill-health, including families, carers and kin. Their stories continue to drive improvements to the mental health system and services. On 30 January 2023, the Government announced $7.5 million in funding to establish and operate two new independent mental health lived experience peak bodies: one representing consumers; and one... MoreClosed 3 November 2023 -
Co-design of the new national mental health lived experience consumer peak body
The Australian Government values the contributions of people with lived and/or living experiences of mental ill-health. Their stories continue to drive improvements to the mental health system and services. On 30 January 2023, the Government announced $7.5 million in funding to establish and operate two new independent mental health lived experience peak bodies: one representing consumers; and one representing families, carers and kin. ... MoreClosed 3 November 2023 -
Medicare Benefits Schedule Review Advisory Committee Draft Report: Post Implementation Review of Telehealth MBS items
The Medicare Benefits Schedule (MBS) is a list of health professional services (items) that the Australian Government subsidises. MBS items provide patient benefits for a wide range of health services including consultations, diagnostic tests, therapy, and operations. When changes are made to MBS items, a review is undertaken approximately 24 months after to analyse and examine the performance of the changes. This is called a post implementation review. Post... MoreClosed 6 November 2023 -
Consultation on the Active Ingredient Prescribing (AIP) Initiative: List of Medicines for Brand Consideration (LMBC)
Active Ingredient Prescribing (AIP) is mandatory for all Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme (RPBS) prescriptions. However, there are circumstances when prescribers may need to include brand name on a prescription, in addition to active ingredient. The Department of Health and Aged Care is seeking prescriber feedback about utilisation of the List of Medicines for Brand Consideration (LMBC) as a support tool to prescribing by... MoreClosed 13 November 2023
328 results.
Page 9 of 11